🎉 Finosauras is now  SarasRead more
Glenmark Life Sciences Ltd logo

Alivus Life Sciences Limited - Share Price Target 2026

(NSE: ALIVUS)

Sector: Chemicals

Market Cap: 1120632.77 Lakh Cr

939.80

-

994.30

Target Price Range

892.40

+15.70 (1.76%)

CMP

Neutral

As on 14 Jan 2026, 01:15 pm

Market Trends

Based on 6 technical indicators.
Bullish0
Bearish1
Neutral5
Agg. Profit Potential3.55%
Agg. Risk 8.67%

Last updated on: 14/01/2026, 1:15 pm

Returns

PeriodReturn %
1 Month-4.03
3 Months-11.60
1 Year--
5 Years--

Last updated on: 06/09/2025, 9:30 AM

Institutional Holdings

InstitutePercentageNo. of Shares
Polar Capital Funds PLC - Healthcare Opportunities2.79%3,423,757
Quant Mutual Fund - Quant Small Cap Fund2.51%3,080,136
Massachusetts Institute of Technology1.23%1,504,000
Government Pension Fund Global1.09%1,331,500

Last updated on: 9/30/2025, 12:00:00 AM

Loading technical analysis...

Fundamental Data

Fundamental Analysis

P/E Ratio

21.13

P/B Ratio

3.72

PEG Ratio

8.73

ROE

18.94%

EPS

43.23

Dividend Yield

0.55%

Market Cap

1120632.77 Lakh Cr

Sector

N/A

Last Updated: 12 Nov 2025, 01:30 pm

Peer Comparison

CompanySentimentTarget PriceUpside

About : Alivus Life Sciences Ltd.

Incorporated Year

2011

City and State

Solapur, Maharashtra

Listing Date

Director's Name

Rudalf Corriea

Revenue

23967.47 Cr

Net Profit

6541.31 Cr